The Team

Zohar is the CEO of NGT3 VC. Former CEO & director of Beta-O2 (developed implantable bio-artificial pancreas). Served as CEO of the Technion Technological Incubator. Led the establishment and investment of more than 50 companies, such as Prolor Biotech (sold to OPKO, NYSE: OPK), Mazor (NASDAQ: MZOR), Corindus (NASDAQ: CVRS), ReWalk (NASDAQ: RWLK), and others.  

Tal holds a B.Sc. in Biomedical Engineering from Ben-Gurion University, and has over 12 years of experience in the medical device industry.  

Dr. Shechter is the head of the Sexual Dysfunction Clinic at Rambam Medical Center, Israel, and a member of the Executive Committee of European Society for Sexual Medicine. Dr. Shechter holds a M.D. from BenGurion University.  
Oded served as an executive in several companies, startups and corporates in Israel, Germany and the US, including GE, Roche GmBH, Medingo (sold to Roche), DoD, and Kornit Digital (NASDAQ:KRNT) in various business leadership, marketing, and R&D roles. Oded holds a B.Sc in EE and MBA from the Technion.